In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection.
about
Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutationsAntiviral and cellular metabolism interactions between Dexelvucitabine and lamivudineAntiretroviral drugs: critical issues and recent advancesVariations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine.Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection.Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions.In vitro interactions between apricitabine and other deoxycytidine analoguesAntiviral activity of apricitabine in treatment-experienced HIV-1-infected patients with M184V who are failing combination therapy.
P2860
Q28235418-D27628AB-F35D-4768-BED6-B57355EFC95DQ35840864-67BA99F8-020A-4EA1-9024-CEE379DF3344Q36020992-F158C365-6815-4C77-B03D-277821FC8988Q36295410-B53C00C6-D215-42A9-B7B8-76D8203DA974Q36836868-72251D42-6F89-4939-9753-E865CA1C5CF3Q37593797-9FC06CA1-7432-470A-8A65-92244CF0216CQ40055204-F00DE74A-BC37-47A8-9C0C-E1988E3FDF4AQ41879018-8339EEB8-D47D-4CCD-8C6C-9F8E34F4EEB4Q42041046-3CA51F1D-4768-400C-9A31-5EFEFB7A66F4Q54634995-D14BE4F8-B868-4375-B5B4-FA0935B25811
P2860
In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
In vitro antiretroviral activi ...... unodeficiency virus infection.
@ast
In vitro antiretroviral activi ...... unodeficiency virus infection.
@en
In vitro antiretroviral activi ...... unodeficiency virus infection.
@nl
type
label
In vitro antiretroviral activi ...... unodeficiency virus infection.
@ast
In vitro antiretroviral activi ...... unodeficiency virus infection.
@en
In vitro antiretroviral activi ...... unodeficiency virus infection.
@nl
prefLabel
In vitro antiretroviral activi ...... unodeficiency virus infection.
@ast
In vitro antiretroviral activi ...... unodeficiency virus infection.
@en
In vitro antiretroviral activi ...... unodeficiency virus infection.
@nl
P2093
P2860
P1476
In vitro antiretroviral activi ...... unodeficiency virus infection.
@en
P2093
D L Taylor
J M de Muys
N Nguyen-Ba
R C Bethell
P2860
P304
P356
10.1128/AAC.50.2.625-631.2006
P407
P577
2006-02-01T00:00:00Z